Ca plus vit D
Small molecule
Ca plus vit D is one of 10 small molecule programs targeting Colorectal Adenoma. It is currently in development.
1
Indications
1
Total Trials
0
Active Trials
9
Competitors
Pipeline
Status by Indication[3][1]
Indication
Competition
Competitive Landscape
15 competitors in Colorectal Adenoma
#DrugCompanyPhaseTrials
1Linzess
AbbVieApproved
Lialda
TakedaApproved
Bayer Aspirin
BayerPhase 3
Glucophage
Boehringer IngelheimPhase 2
Celebrex
PPhiladelphia Eye Associates
Phase 2
Berberine Hydrochloride
XXijing Hospital of Digestive Diseases
Phase 3
Mesalazine
FerringPhase 2
Acetylsalicylic Acid Lysinate
MMedical University of Vienna
Phase 3
Berberine
XXijing Hospital of Digestive Diseases
Phase 2
Ca plus vit D
SShanghai Jiao Tong University School of Medicine
Preclinical
Ranked by pipeline maturity and clinical activity. Current drug highlighted in teal.
Clinical
Trials by Indication[1]
Sources
References
- [1]
- [2]
- [3]Open Targets Platform — Drug–disease associations for Ca plus vit D. EMBL-EBI & Wellcome Sanger Institute.
- [4]
Details
Drug Info
Quick Facts
- Modality
- Small molecule[2]